Shionogi & Co., Ltd.

4507.T
Drug Manufacturers - Specialty & Generic
2026/08/21 Updated
Market Cap: $15.7B (¥2.5T)
Stock Price: $18.45 (¥2,933)
Exchange Rate: 1 USD = ¥158.98

Conclusion of Bridge Loan Agreement Related to Additional Investment in ViiV Healthcare Ltd.

Shionogi & Co., Ltd. has concluded a 300 billion yen bridge loan agreement on March 27, 2026, related to an additional investment in ViiV Healthcare Ltd., with borrowing execution planned for March 31.

Importance:
Page Updated: March 27, 2026
IR Disclosure Date: March 27, 2026

Key Figures

  • Loan Amount: 300 billion yen (bridge loan related to additional investment in ViiV Healthcare Ltd.)
  • Lender: Sumitomo Mitsui Banking Corporation
  • Final Repayment Date: 2027-03-26

AI要約

Overview of Loan Agreement

Shionogi & Co., Ltd. concluded a 300 billion yen bridge loan agreement with Sumitomo Mitsui Banking Corporation on March 27, 2026, relating to the additional investment in ViiV Healthcare Ltd. announced on January 20, 2026. The loan execution date is March 31, 2026, with an interest rate composed of the base rate plus a spread, unsecured. The final repayment date is March 26, 2027.

Outlook and Impact on Performance

The procured funds are planned to be refinanced into medium- to long-term funds by the repayment deadline. The impact on consolidated earnings forecast for the fiscal year ending March 2026 is considered minor, while the impact on the fiscal year ending March 2027 is currently under review and will be promptly disclosed as necessary. Additionally, including a bridge loan related to the acquisition from Tanabe Pharma around the same period, total fund procurement amounts to 660 billion yen.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Shionogi & Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →